{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:08:39Z","timestamp":1779005319177,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030-204978"],"award-info":[{"award-number":["320030-204978"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110874","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:10:40Z","timestamp":1770657040000},"page":"110874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["N,N-dimethyltryptamine (DMT) is neither formed nor retained in serotonin terminals in the rat brain"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6014-2084","authenticated-orcid":false,"given":"Mikael","family":"Palner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9643-0373","authenticated-orcid":false,"given":"Elisabeth","family":"Kolesnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-9200","authenticated-orcid":false,"given":"Christina","family":"Baun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-9263","authenticated-orcid":false,"given":"Sandra N.","family":"Poetzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-9621","authenticated-orcid":false,"given":"Paul","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3475","key":"10.1016\/j.neuropharm.2026.110874_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.134.3475.343","article-title":"Enzymatic formation of psychotomimetic metabolites from normally occurring compounds","volume":"134","author":"Axelrod","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110874_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111259","article-title":"N, N-dimethyltryptamine (DMT) in rodent brain: concentrations, distribution, and recent pharmacological data","volume":"137","author":"Barker","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7-8","key":"10.1016\/j.neuropharm.2026.110874_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2026.110874_bib4","article-title":"Pharmacodynamic effects and plasma pharmacokinetics of N, N-dimethyltryptamine after intranasal versus subcutaneous administration in male rats","author":"Baumann","year":"2025","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110874_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0047-6374(84)90007-1","article-title":"Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats","volume":"25","author":"Beaton","year":"1984","journal-title":"Mech. Ageing Dev."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-2944(77)90088-6","article-title":"The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent","volume":"18","author":"Christian","year":"1977","journal-title":"Biochem. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110874_bib7","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J. Neural Transm."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110874_bib8","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1471-4159.1992.tb11026.x","article-title":"Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study","volume":"59","author":"Cumming","year":"1992","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/syn.890150204","article-title":"Kinetics of the uptake of [3H]paroxetine in the rat brain","volume":"15","author":"Cumming","year":"1993","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110874_bib10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1471-4159.1995.65031381.x","article-title":"Regulation of DOPA decarboxylase activity in brain of living rat","volume":"65","author":"Cumming","year":"1995","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110874_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/jcbfm.1993.85","article-title":"Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans","volume":"13","author":"Cumming","year":"1993","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1098-2396(199911)34:2<124::AID-SYN5>3.0.CO;2-O","article-title":"Pharmacokinetics of radiotracers in human plasma during positron emission tomography","volume":"34","author":"Cumming","year":"1999","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110874_bib13","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1038\/s41598-019-45812-w","article-title":"Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain","volume":"9","author":"Dean","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110874_bib14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1471-4159.1980.tb11267.x","article-title":"Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain","volume":"34","author":"Durden","year":"1980","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110874_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00018-024-05353-6","article-title":"Neurobiological research on N,N-Dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors","volume":"81","author":"Egger","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2026.110874_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1140656","article-title":"A pilot study of cerebral metabolism and serotonin 5-HT(2A) receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine","volume":"14","author":"Egger","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110874_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117908","article-title":"Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: \u03b1 factorial dose-escalation study","volume":"184","author":"Egger","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110874_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.2042-7158.1987.tb06973.x","article-title":"Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homovanillic acid in rat brain","volume":"39","author":"Emanuelsson","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.2042-7158.1984.tb03004.x","article-title":"On the substrate specificities of the two forms of monoamine oxidase","volume":"36","author":"Fowler","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10571-020-00800-x","article-title":"Trace amines and trace amine-associated receptors: a new frontier in cell signaling","volume":"40","author":"Freyberg","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110874_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0028-3908(95)00049-C","article-title":"Tissue distribution, metabolism and effects of bufotenine administered to rats","volume":"34","author":"Fuller","year":"1995","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110874_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0969-8051(00)00187-6","article-title":"Kinetics of the metabolism of four PET radioligands in living minipigs","volume":"28","author":"Gillings","year":"2001","journal-title":"Nucl. Med. Biol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110874_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0006-2952(66)90175-4","article-title":"Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions","volume":"15","author":"Glowinski","year":"1966","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110874_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/02698811221104054","article-title":"Significance of mammalian N, N-dimethyltryptamine (DMT): a 60-year-old debate","volume":"36","author":"Jim\u00e9nez","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/acschemneuro.1c00660","article-title":"Pharmahuasca and DMT rescue ROS production and differentially expressed genes observed after predator and psychosocial stress: relevance to human PTSD","volume":"13","author":"Kelley","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110874_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113615","article-title":"Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; method development and application","volume":"191","author":"K\u00f6rm\u00f6czi","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.neuropharm.2026.110874_bib27","article-title":"Indolealkylamine analogs share 5-HT 2 binding characteristics with phenylalkylamine hallucinogens","volume":"145","author":"Lyon","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110874_bib28","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/jxb\/ers091","article-title":"The pathway of auxin biosynthesis in plants","volume":"63","author":"Mano","year":"2012","journal-title":"J. Exp. Bot."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110874_bib29","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/jnc.13370","article-title":"Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain","volume":"135","author":"Maschauer","year":"2015","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110874_bib30","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.09-10-03482.1989","article-title":"Differentiation of 5-Hydroxytryptamine, receptor subtypes using 125 l-R-(-)2,5-Dimethoxy-4-iodo-phenylisopropylamine and 3H-Ketanserin","volume":"9","author":"McKenna","year":"1989","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110874_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","article-title":"Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes","volume":"29","author":"McKenna","year":"1990","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110874_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11041147","article-title":"Ayahuasca as a decoction applied to human: analytical methods, pharmacology and potential toxic effects","volume":"11","author":"Ni\u017enansk\u00fd","year":"2022","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110874_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1139\/o74-068","article-title":"Identification and distribution of tryptamine in the rat","volume":"52","author":"Philips","year":"1974","journal-title":"Can. J. Biochem."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110874_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111618","article-title":"Molecular pathways of the therapeutic effects of ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant","volume":"12","author":"Rossi","year":"2022","journal-title":"Biomolecules"},{"issue":"4028","key":"10.1016\/j.neuropharm.2026.110874_bib35","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.175.4028.1365","article-title":"Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro","volume":"175","author":"Saavedra","year":"1972","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3565(25)29764-6","article-title":"The elimination of 5-hydroxyindoleacetic acid from cerebrospinal fluid: characteristics of the acid transport system of the choroid plexus","volume":"188","author":"Sampath","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110874_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1748-1716.1974.tb05601.x","article-title":"Labelled 5-hydroxytryptamine and 5-hydroxyindoleacetic acid formed in vivo from 3H-tryptophan in rat brain effect of probenecid","volume":"90","author":"Schubert","year":"1974","journal-title":"Acta Physiol. Scand."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.110874_bib38","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/0006-2952(86)90421-1","article-title":"The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues","volume":"35","author":"Sullivan","year":"1986","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110874_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02002839","article-title":"Effects of tranylcypromine and pargyline on brain tryptamine","volume":"33","author":"Tabakoff","year":"1977","journal-title":"Experientia"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110874_bib40","first-page":"2252","article-title":"In vivo imaging of the brain vesicular monoamine transporter","volume":"36","author":"Vander Borght","year":"1995","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110874_bib41","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2967\/jnumed.110.083246","article-title":"In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine","volume":"52","author":"Vitale","year":"2011","journal-title":"J. Nucl. Med."},{"issue":"1-2","key":"10.1016\/j.neuropharm.2026.110874_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(93)91664-E","article-title":"Intracellular distribution of monoamine oxidase A in selected regions of rat and monkey brain and spinal cord","volume":"612","author":"Westlund","year":"1993","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110874_bib43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.1980.tb09944.x","article-title":"The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid","volume":"34","author":"Young","year":"1980","journal-title":"J. Neurochem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082600047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082600047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:57:38Z","timestamp":1779004658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082600047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S002839082600047X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110874","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N,N-dimethyltryptamine (DMT) is neither formed nor retained in serotonin terminals in the rat brain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110874"}}